Cardiovascular Disease Doctors in San Gabriel, CA Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Dr. Greg Shih-han Yen, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 131 E Las Tunas Dr, San Gabriel, CA 91776 Phone: 626-576-8500    Fax: 626-576-8050

Peter Zihao Xu, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 506 W Valley Blvd Ste 100, San Gabriel, CA 91776 Phone: 626-308-3800

Dr. Yih Jen Kok, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 506 W Valley Blvd, San Gabriel, CA 91776 Phone: 626-308-3800    Fax: 626-308-1899

Dr. Kelvin K Yee, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 559 W Las Tunas Dr, San Gabriel, CA 91776 Phone: 626-457-9618    Fax: 626-457-9242

News Archive

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Researchers studying two generations of a family affected by pediatric acute lymphoblastic leukemia (ALL) have identified an inherited variation in the ETV6 gene that is associated with an increased risk of developing the disease. St. Jude Children's Research Hospital investigators led the study, which appears in the October 28 issue of the journal Lancet Oncology.

Free insecticidal bednets, not social marketing, key to controlling malaria in Africa

The London School of Hygiene and Tropical Medicine's Professor Chris Curtis has joined the Earth Institute's Professor Jeffrey Sachs to call for the mass distribution of free insecticidal bed nets to replace social marketing as a means of controlling malaria in Africa.

ExonHit Therapeutics obtains "Innovative Company" accreditation

ExonHit Therapeutics today announced that it has obtained the "Innovative Company" accreditation from OSEO (the French state innovation agency), in recognition of the company's cutting-edge innovations in its target sectors.

Study examine effect of high out-of-pocket drug costs for targeted cancer therapies on patients

The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient's share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.

FDA proposed rules address industry, consumer concerns

The Food and Drug Administration may tighten rules for approving medical devices that are only slightly different from already-blessed products, The Chicago Tribune reports.

Read more Medical News

› Verified 8 days ago